BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 15755600)

  • 1. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
    Frasch CE; Borrow R; Donnelly J
    Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials.
    Martin D; McCallum L; Glennie A; Ruijne N; Blatchford P; O'Hallahan J; Oster P
    Vaccine; 2005 Mar; 23(17-18):2218-21. PubMed ID: 15755599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
    Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E
    Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
    Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
    Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection.
    Williams JN; Jones GR; Christodoulides M; Heckels JE
    J Infect Dis; 2003 May; 187(9):1433-41. PubMed ID: 12717625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
    Lucidarme J; Louth J; Townsend-Payne K; Borrow R
    Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal antibody assays - The role of complement in infection and immunity.
    McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
    Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay.
    Ison CA; Anwar N; Cole MJ; Galassini R; Heyderman RS; Klein NJ; West J; Pollard AJ; Morley S; Levin and the Meningococcal Re
    Microb Pathog; 1999 Oct; 27(4):207-14. PubMed ID: 10502461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
    Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.
    Jordens JZ; Williams JN; Jones GR; Christodoulides M; Heckels JE
    Infect Immun; 2004 Nov; 72(11):6503-10. PubMed ID: 15501781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
    Giuliani MM; Biolchi A; Serruto D; Ferlicca F; Vienken K; Oster P; Rappuoli R; Pizza M; Donnelly J
    Vaccine; 2010 Jul; 28(31):5023-30. PubMed ID: 20493284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.